Darovasertib (LXS196) is a potent, selective and orally active protein kinase C (PKC) inhibitor, with IC50 values of 1.9 nM, 0.4 nM and 3.1 µM for PKCalpha, PKCtheta and GSK3beta, respectively. Darovasertib has the potential for uveal melanoma research[1][2].
Molecular Weight:
472.47
Purity:
99.18
CAS Number:
[1874276-76-2]
Formula:
C22H23F3N8O
Target:
PKC
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted
